Literature DB >> 3556425

Inhibition of the phagocytosis-induced respiratory burst by the fungal metabolite wortmannin and some analogues.

M Baggiolini, B Dewald, J Schnyder, W Ruch, P H Cooper, T G Payne.   

Abstract

The sterol-like fungal metabolite wortmannin and a number of natural and chemically-derived analogues were found to block the induction of the respiratory burst during phagocytosis. 17-Hydroxy wortmannin, the most active compound tested, showed a 50% inhibition of the burst in neutrophils and mononuclear phagocytes at concentrations ranging between 0.8 and 17 nM, while wortmannin itself was about half as potent. Chemical derivation showed that a furane structure between ring A and B with adjacent carbonyl functions is essential for activity. At concentrations that entirely prevented superoxide or hydrogen peroxide production, the wortmannins were not cytotoxic and did not inhibit phagocytosis. At even higher concentrations (10 microM), 17-hydroxy wortmannin had no effect on the NADPH oxidase, once activated. This suggests that the wortmannins interfere with the signal transduction sequence initiated by the particulate stimulus and leading to the activation of the respiratory burst oxidase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556425     DOI: 10.1016/0014-4827(87)90201-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  26 in total

Review 1.  Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

Authors:  Paul Workman; Paul A Clarke; Florence I Raynaud; Rob L M van Montfort
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  The role of phosphatidylinositol-3-kinase in the formation of oxygen radicals by phagocytes in whole blood samples from patients with coronary heart disease.

Authors:  E I Astashkin; N D Egorova; N S Orekhova; A N Novikova; M G Glezer; S V Grachev
Journal:  Dokl Biol Sci       Date:  2006 Jan-Feb

3.  Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.

Authors:  M P Wymann; G Bulgarelli-Leva; M J Zvelebil; L Pirola; B Vanhaesebroeck; M D Waterfield; G Panayotou
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Fc gamma R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome.

Authors:  Wei Tian; Xing Jun Li; Natalie D Stull; Wenyu Ming; Chang-Il Suh; Sarah A Bissonnette; Michael B Yaffe; Sergio Grinstein; Simon J Atkinson; Mary C Dinauer
Journal:  Blood       Date:  2008-08-18       Impact factor: 22.113

5.  Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus.

Authors:  B Schnyder; P C Meunier; B D Car
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

6.  Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase gamma: structure-activity analysis and interactions with wortmannin.

Authors:  S Stoyanova; G Bulgarelli-Leva; C Kirsch; T Hanck; R Klinger; R Wetzker; M P Wymann
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 7.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

8.  Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts.

Authors:  M Wymann; A Arcaro
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

9.  Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes.

Authors:  M Thelen; M P Wymann; H Langen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 10.  Probing the probes: fitness factors for small molecule tools.

Authors:  Paul Workman; Ian Collins
Journal:  Chem Biol       Date:  2010-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.